ACADIA Pharmaceuticals
ACAD
#3905
Rank
A$3.78 B
Marketcap
$22.81
Share price
-1.11%
Change (1 day)
-31.70%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): A$64.94 M

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings (TTM) are A$68.61 M. In 2023 the company made an earning of -A$76.55 M an increase over its 2022 earnings that were of -A$0.33 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$64.94 M-184.84%
2023 -A$76.55 M-76.09%
2022 -A$0.33 B27.41%
2021 -A$0.26 B-40.38%
2020 -A$0.43 B19.88%
2019 -A$0.36 B-3.92%
2018 -A$0.37 B-15.04%
2017 -A$0.44 B6.33%
2016 -A$0.41 B64.55%
2015 -A$0.25 B77.47%
2014 -A$0.14 B143.69%
2013 -A$56.92 M81.93%
2012 -A$31.29 M-8.73%
2011 -A$34.28 M-251.39%
2010 A$22.64 M-133.2%
2009 -A$68.2 M-30.82%
2008 -A$98.58 M6.43%
2007 -A$92.63 M25.89%
2006 -A$73.58 M36.99%
2005 -A$53.71 M37.22%
2004 -A$39.14 M19.96%
2003 -A$32.63 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$48.71 M-170.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.82 B-2,749.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$13.48 B 19,551.32%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.40 B 44,218.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$9.63 B-14,132.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$57.94 M-184.45%๐Ÿ‡บ๐Ÿ‡ธ USA